MSJCX Mutual Fund

NAV$21.35

Fund Essentials - as of Mar 31, 2026

Net Assets
-
Expense Ratio
2.10%
Dividend Yield (Current)
-
Holdings
36
Inception Date
Dec 31, 2018
Fund Family
Morgan Stanley Investment Management
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+10.63%
1 Year+24.71%
3 Year+15.02%
5 Year-8.40%

Asset Allocation

Stocks: 98.07%
Other: 1.93%

Price Chart (6M)

Loading chart data...

Top Holdings

View All →
TickerNameWeight
ROIV:BMRoivant Sciences Ltd8.75%
VCP:LNVictoria Plc7.90%
QXOQxo Inc Pipe 0.000000005.37%
TFXTeleflex Inc.5.14%
CLMTCalumet Inc.4.67%
Top 10 Concentration: 51.80%Report Date: Mar 31, 2026
Download all 36 holdings for MSJCX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Frequency
Annually
Latest Distribution
$1.30
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO
See how MSJCX ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
$49$29/mo
Claim the $29 launch price
First 500 subscribers, then $49/mo. Cancel anytime. From MarketXLS, trusted since 2014.

MSJCX Mutual Fund Overview

MSJCX Mutual Fund (Global Endurance Portfolio - Class C) is managed by Morgan Stanley Investment Management. MSJCX expense ratio is 2.10%, holding 36 positions across sectors including Health Care, Information Technology, Consumer Discretionary. Inception date: 2018-12-31.

MSJCX performance shows a YTD return of 10.63%. The 1-year return is 24.71% and the 5-year return is -8.40%.

MSJCX top holdings include Roivant Sciences Ltd (8.8%), Victoria Plc (7.9%), Qxo Inc Pipe 0.00000000 (5.4%), Teleflex Inc. (5.1%), Calumet Inc. (4.7%). View all MSJCX holdings, sector breakdown, or dividend history.

MSJCX can be compared against other funds using the overlap calculator or side-by-side comparison tool. MSJCX alternatives are available via the screener, along with tax-loss harvesting opportunities.